Your browser is no longer supported. Please, upgrade your browser.
Pulse Biosciences, Inc.
Index- P/E- EPS (ttm)-2.32 Insider Own56.91% Shs Outstand29.61M Perf Week-4.87%
Market Cap357.91M Forward P/E- EPS next Y-1.70 Insider Trans0.00% Shs Float12.77M Perf Month-24.06%
Income-62.00M PEG- EPS next Q-0.50 Inst Own14.00% Short Float12.83% Perf Quarter-44.84%
Sales0.60M P/S596.52 EPS this Y5.30% Inst Trans-1.29% Short Ratio21.70 Perf Half Y-46.61%
Book/sh1.60 P/B7.08 EPS next Y25.10% ROA-92.20% Target Price35.33 Perf Year-67.09%
Cash/sh1.33 P/C8.52 EPS next 5Y- ROE-164.80% 52W Range10.03 - 45.82 Perf YTD-23.50%
Dividend- P/FCF- EPS past 5Y-57.10% ROI- 52W High-75.27% Beta1.64
Dividend %- Quick Ratio4.70 Sales past 5Y- Gross Margin-26.70% 52W Low12.96% ATR1.12
Employees95 Current Ratio5.20 Sales Q/Q- Oper. Margin- RSI (14)27.47 Volatility12.74% 8.49%
OptionableYes Debt/Eq0.02 EPS Q/Q5.70% Profit Margin- Rel Volume2.13 Prev Close12.16
ShortableYes LT Debt/Eq0.00 EarningsNov 15 AMC Payout- Avg Volume75.47K Price11.33
Recom1.70 SMA20-13.49% SMA50-30.78% SMA200-41.74% Volume160,399 Change-6.83%
Jul-27-21Initiated Stephens Overweight $28
Mar-11-21Initiated Maxim Group Buy $40
Jan-26-21Reiterated H.C. Wainwright Buy $16 → $40
May-12-20Upgrade H.C. Wainwright Neutral → Buy $6 → $16
Feb-14-20Downgrade H.C. Wainwright Buy → Neutral $26 → $6
Feb-25-19Initiated H.C. Wainwright Buy $27
Jan-11-22 07:00AM  
Dec-28-21 02:38AM  
Dec-17-21 09:20AM  
Nov-25-21 10:00AM  
Nov-18-21 04:05PM  
Nov-15-21 04:05PM  
Nov-04-21 04:05PM  
Nov-02-21 04:05PM  
Oct-05-21 08:00AM  
Sep-02-21 04:05PM  
Aug-19-21 04:05PM  
Aug-09-21 04:05PM  
Jul-26-21 04:05PM  
Jul-06-21 01:34AM  
Jul-01-21 05:45PM  
Jun-30-21 10:56AM  
Jun-11-21 06:17AM  
Jun-09-21 09:05AM  
May-24-21 08:00AM  
May-13-21 09:16AM  
May-11-21 07:17AM  
May-10-21 04:05PM  
Apr-26-21 04:05PM  
Apr-22-21 08:00AM  
Mar-12-21 03:19AM  
Mar-05-21 08:00AM  
Feb-22-21 04:05PM  
Feb-20-21 09:36AM  
Feb-19-21 08:00AM  
Feb-16-21 08:00AM  
Feb-12-21 08:00AM  
Feb-04-21 08:30AM  
Feb-03-21 09:00AM  
Jan-25-21 08:00AM  
Jan-12-21 07:00AM  
Jan-11-21 06:11AM  
Jan-05-21 09:00AM  
Dec-15-20 04:38PM  
Dec-04-20 08:00AM  
Nov-11-20 04:05PM  
Nov-09-20 08:30PM  
Oct-28-20 04:05PM  
Oct-07-20 07:30AM  
Oct-01-20 07:30AM  
Sep-29-20 07:30AM  
Sep-15-20 04:14PM  
Sep-01-20 04:05PM  
Aug-11-20 01:30AM  
Aug-10-20 04:05PM  
Aug-06-20 04:05PM  
Jul-27-20 04:05PM  
Jul-01-20 04:05PM  
Jun-16-20 08:12PM  
Jun-10-20 09:10AM  
Jun-08-20 06:46PM  
May-14-20 05:38PM  
May-11-20 04:05PM  
May-01-20 09:10AM  
Apr-29-20 04:05PM  
Apr-24-20 07:24AM  
Apr-21-20 09:46AM  
Apr-06-20 09:10AM  
Mar-17-20 04:05PM  
Mar-16-20 04:05PM  
Mar-09-20 04:46PM  
Feb-14-20 08:23AM  
Feb-13-20 05:44PM  
Jan-29-20 09:41PM  
Jan-20-20 11:07AM  
Dec-30-19 06:35AM  
Dec-18-19 09:00AM  
Dec-16-19 05:26PM  
Nov-18-19 08:32PM  
Nov-07-19 03:44PM  
Oct-31-19 01:51PM  
Oct-22-19 11:53AM  
Oct-17-19 07:52PM  
Oct-15-19 07:40PM  
Oct-01-19 04:34PM  
Sep-17-19 09:02PM  
Sep-04-19 07:01PM  
Aug-21-19 10:16AM  
Aug-16-19 04:56PM  
Aug-09-19 04:24AM  
Aug-08-19 04:02PM  
Aug-06-19 08:00AM  
Jul-25-19 04:20PM  
Jun-17-19 07:22PM  
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue primarily for dermatology applications by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.